The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Open accessAbstract
Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has illuminated the extensive intertumoral heterogeneity of medulloblastoma, identifying four distinct molecular subgroups. Group 3 and group 4 subgroup medulloblastomas account for most paediatric cases; yet, oncogenic drivers for these subtypes remain largely unidentified. Here we describe a series of prevalent, highly disparate genomic structural variants, restricted to groups 3 and 4, resulting in specific and mutually exclusive activation of the growth factor independent 1 family proto-oncogenes, GFI1 and GFI1B. Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity. Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies have shown that the ‘hijacking’ of enhancers can lead to overexpression of oncogenes (for example, growth factor independent 1 family oncogenes (GFI1 and GFI1B)) in medulloblastoma13”
From Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (2020) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,063
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Krueger, F., & Andrews, S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr167 · Cited by 5,324
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Mapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 649
Phi, J. H., Choi, S. A., Kwak, P. A., Lee, J. Y., Wang, K., Hwang, D. W., & Kim, S. (2017) · Oncotarget · doi:10.18632/oncotarget.18132 · Cited by 23
Doussouki, M. E., Gajjar, A. J., & Chamdine, O. (2019) · Future Neurology · doi:10.2217/fnl-2018-0030 · Cited by 23
Self-citationMontefiori, L. E., & Mullighan, C. G. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101329 · Cited by 25
Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
Napoli, S., Munz, N., Guidetti, F., & Bertoni, F. (2022) · Cancers · doi:10.3390/cancers14081978 · Cited by 23
Yamamoto, T., Sato, Y., Yasuda, S., Shikamura, M., Tamura, T., Takenaka, C., Takasu, N., Nomura, M., Dohi, H., Takahashi, M., et al. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac014 · Cited by 22
Regulation of 3D Organization and Its Role in Cancer Biology
Peng, A., Peng, W., Wang, R., Zhao, H., Yu, X., & Sun, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.879465 · Cited by 22
The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino, S., & Suzuki, H. I. (2022) · PubMed Central · doi:10.18999/nagjms.84.2.216 · Cited by 23
The 3D genome and its impacts on human health and disease
Wang, S., Luo, Z., Liu, W., Hu, T., Zhao, Z., Rosenfeld, M. G., & Song, X. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad012 · Cited by 22
miR miR on the wall, who’s the most malignant medulloblastoma miR of them all?
Wang, X., Holgado, B., Ramaswamy, V., Mack, S. C., Zayne, K., Remke, M., Wu, X., Garzia, L., Daniels, C. E., Kenney, A. M., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox106 · Cited by 22
Self-citationZhang, X., Wang, Y., Chiang, H.-C., Hsieh, Y.-P., Lu, C., Park, B. H., Jatoi, I., Jin, V. X., Hu, Y., & Li, R. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1132-1 · Cited by 22
DNA methylation at enhancer regions Novel avenues for epigenetic biomarker development
Helgason, C. D. (2015) · Frontiers in bioscience · doi:10.2741/4399 · Cited by 24
Mikulášová, A., Kent, D., Trevisán-Herraz, M., Karataraki, N., Fung, K. T. M., Ashby, C., Cieślak, A., Yaccoby, S., van Rhee, F., Zangari, M., et al. (2021) · Genome Research · doi:10.1101/gr.276042.121 · Cited by 22
Transposable elements: a jump toward the future of expression vectors
Palazzo, A., & Marsano, R. M. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1888067 · Cited by 21
Nargund, A. M., Xu, C., Mandoli, A., Okabe, A., Chen, G. B., Huang, K. K., Sheng, T., Yao, X., Teo, J. M. N., Sundar, R., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2072 · Cited by 21
Long-range gene regulation in hormone-dependent cancer
Tettey, T. T., Rinaldi, L., & Hager, G. L. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00603-4 · Cited by 23
Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma
Yuan, C., Hu, H., Kuang, M., Chen, Z., Tao, X., Fang, S., Sun, Y., Zhang, Y., & Chen, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22165 · Cited by 21
EnDisease: a manually curated database for enhancer-disease associations
Zeng, W., Xu, M., & Jiang, R. (2019) · Database · doi:10.1093/database/baz020 · Cited by 21
da Silva, L. S., Mançano, B. M., de Paula, F. E., dos Reis, M. B., de Almeida, G. C., Matsushita, M., Carlos, A., Evangelista, A. F., Saggioro, F. P., Serafini, L. N., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.04.207 · Cited by 21
Self-citationMizokami, H., Okabe, A., Choudhary, R., Mima, M., Saeda, K., Fukuyo, M., Rahmutulla, B., Seki, M., Goh, B.-C., Kondo, S., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105057 · Cited by 20
Immuno-oncology from the perspective of somatic evolution
González, S., Volkova, N. V., Beer, P. A., & Gerstung, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.001 · Cited by 20
Ghavi-Helm, Y. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.09.010 · Cited by 20
Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors
Hawley, J. R., Zhou, S., Arlidge, C., Grillo, G., Kron, K. J., Hugh-White, R., van der Kwast, T. H., Fraser, M. E., Boutros, P. C., Bristow, R. G., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2056 · Cited by 21
The Impact of Space and Time on the Functional Output of the GenomePreprint
Nollmann, M., Bennabi, I., Götz, M., & Gregor, T. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040378 · Cited by 23
Regner, M. J., García‐Recio, S., Thennavan, A., Wiśniewska, K., Méndez-Giráldez, R., Felsheim, B., Spanheimer, P. M., Parker, J. S., Perou, C. M., & Franco, H. L. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100765 · Cited by 20
The Emerging Molecular Foundations of Pediatric Brain Tumors
Huse, J. T., & Rosenblum, M. K. (2015) · Journal of Child Neurology · doi:10.1177/0883073815579709 · Cited by 19
Henderson, J., Ly, V., Olichwier, S., Chainani, P., Liu, Y., & Soibam, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz315 · Cited by 19
Cross-species enhancer prediction using machine learning
MacPhillamy, C., Alinejad‐Rokny, H., Pitchford, W. S., & Low, W. Y. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110454 · Cited by 20
Weischenfeldt, J., & Ibrahim, D. M. (2023) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2023.102048 · Cited by 19
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Rautajoki, K. J., Jaatinen, S., Hartewig, A., Tiihonen, A. M., Annala, M., Salonen, I., Valkonen, M., Simola, V., Vuorinen, E. M., Kivinen, A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01669-9 · Cited by 20
Medulloblastoma drugs in development: Current leads, trials and drawbacks
Wen, J., & Hadden, M. K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113268 · Cited by 19
Warwick, T., Schulz, M. H., Gilsbach, R., Brandes, R. P., & Seuter, S. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac178 · Cited by 16
Chromatin Mechanisms Driving CancerPreprint
Gryder, B. E., Scacheri, P. C., Ried, T., & Khan, J. I. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040956 · Cited by 20
Bohannan, Z. S., & Mitrofanova, A. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.04.002 · Cited by 18
Notch1 switches progenitor competence in inducing medulloblastoma
Ballabio, C., Gianesello, M., Lago, C., Okonechnikov, K., Anderle, M., Aiello, G., Antonica, F., Zhang, T., Gianno, F., Giangaspero, F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd2781 · Cited by 18
Self-citationThree‐dimensional genome structure and function
Liu, H., Tsai, H., Yang, M., Li, G., Bian, Q., Ding, G., Wu, D., & Dai, J. (2023) · MedComm · doi:10.1002/mco2.326 · Cited by 25
Characterization of Structural Variations in the Context of 3D Chromatin Structure.
Kim, K., Eom, J., & Jung, I. (2019) · PubMed Central · doi:10.14348/molcells.2019.0137 · Cited by 18
Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samples
Wang, Q., Wang, J., Mathur, R., Youngblood, M. W., Jin, Q., Hou, Y., Stasiak, L. A., Luan, Y., Zhao, H., Hilz, S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adn2830 · Cited by 18
Kim, K., Kim, M., Lee, A., Song, S., Kang, J., Eom, J., Kang, G. H., Bae, J. M., Min, S., Kim, Y. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112778 · Cited by 17
Kolekar, P. S., Balagopal, V., Dong, L., Liu, Y., Foy, S. G., Tran, Q., Mulder, H. L., Huskey, A. L. W., Plyler, E. M., Liang, Z., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1063 · Cited by 17
Molecular Basis of Pediatric Brain Tumors
Κλώνου, Α., Piperi, C., Gargalionis, A. N., & Papavassiliou, A. G. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8455-9 · Cited by 17
3D Genome Organization Influences the Chromosome Translocation Pattern
McCord, R. P., & Balajee, A. S. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0593-1_8 · Cited by 18
The clinical implementation of copy number detection in the age of next-generation sequencing
Hehir‐Kwa, J. Y., Tops, B. B. J., & Kemmeren, P. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1523723 · Cited by 18
Clinical and pre-clinical utility of genomics in medulloblastoma
Nör, C., & Ramaswamy, V. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1503536 · Cited by 17
3D or Not 3D: Shaping the Genome during DevelopmentPreprint
Glaser, J., & Mundlos, S. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040188 · Cited by 18
Epigenomic features revealed by ATAC‐seq impact transgene expression in CHO cells
Lee, Z., Raabe, M., & Hu, W. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27701 · Cited by 16
Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
Cao, Z., Shu, Y., Wang, J., Wang, C., Feng, T., Li, Y., Shao, J., & Zou, L. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.01.006 · Cited by 16
Rao, H., Zhang, H., Zou, Y., Ma, P., Huang, T., Yuan, H., Zhou, J., Wan, L., Li, Q., Huang, S., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1248755 · Cited by 16
Weichenhan, D., Riedel, A., Sollier, E., Toprak, U. H., Hey, J., Breuer, K., Wierzbińska, J. A., Touzart, A., Lutsik, P., Bähr, M., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023012161 · Cited by 17
Lewis, M. W., King, C. M., Wiśniewska, K., Regner, M. J., Coffey, A. R., Kelly, M. R., Méndez-Giráldez, R., Davis, E. S., Phanstiel, D. H., & Franco, H. L. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3995 · Cited by 16
Chromatin remodeling defects in pediatric brain tumors
Κλώνου, Α., Spiliotakopoulou, D., Themistocleous, M. S., Piperi, C., & Papavassiliou, A. G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.08 · Cited by 16
An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
Morabito, M., Larcher, M., Cavalli, F. M. G., Foray, C., Forget, A., Mirabal-Ortega, L., Andrianteranagna, M. J. D. D., Druillennec, S., Garancher, A., Masliah‐Planchon, J., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809830 · Cited by 16
Self-citationThe Non-coding Side of Medulloblastoma
Laneve, P., & Caffarelli, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00275 · Cited by 17
Core-binding factor leukemia hijacks the T-cell–prone PU.1 antisense promoter
van der Kouwe, E., Heller, G., Czibere, A. G., Pulikkan, J. A., Agreiter, C., Castilla, L. H., Delwel, R., Ruscio, A. D., Ebralidze, A. K., Forte, M., et al. (2021) · Blood · doi:10.1182/blood.2020008971 · Cited by 16
Three-dimensional regulatory hubs support oncogenic programs in glioblastoma
Breves, S. L., Giammartino, D. C. D., Nicholson, J., Cirigliano, S. M., Mahmood, S. R., Lee, U. J., Martinez‐Fundichely, A., Jungverdorben, J., Singhania, R., Rajkumar, S., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2025.03.007 · Cited by 15
Disruption of regulatory domains and novel transcripts as disease‐causing mechanisms
Allou, L., & Mundlos, S. (2023) · BioEssays · doi:10.1002/bies.202300010 · Cited by 15
Surviving the hunger games: Metabolic reprogramming in medulloblastoma
Manfreda, L., Rampazzo, E., Persano, L., Viola, G., & Bortolozzi, R. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115697 · Cited by 15
Frank, D., Patnana, P. K., Vorwerk, J., Mao, L., Gopal, L. M., Jung, N., Hennig, T., Ruhnke, L., Frenz, J. M., Kuppusamy, M., et al. (2023) · Blood · doi:10.1182/blood.2022015752 · Cited by 15
Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL
Rivera-Reyes, A., Hayer, K. E., & Bassing, C. H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.10.004 · Cited by 15
Hi-C as a molecular rangefinder to examine genomic rearrangements
Kim, K., Kim, M., Kim, Y., Lee, D.-S., & Jung, I. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.04.024 · Cited by 16
Ng, A. W. T., Contino, G., Killcoyne, S., Devonshire, G., Hsu, R., Abbas, S., Su, J., Redmond, A. M., Weaver, J. M. J., Eldridge, M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03238-7 · Cited by 15
Sister chromatid–sensitive Hi-C to map the conformation of replicated genomes
Mitter, M., Takács, Z., Köcher, T., Micura, R., Langer, C. C. H., & Gerlich, D. W. (2022) · Nature Protocols · doi:10.1038/s41596-022-00687-6 · Cited by 16
CRISPR-engineered genome editing for the next generation neurological disease modeling
Feng, W., Liu, H., & Kawauchi, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.019 · Cited by 15
Self-citationIchiyama‐Kobayashi, S., Hata, K., Wakamori, K., Takahata, Y., Murakami, T., Yamanaka, H., Takano, H., Yao, R., Uzawa, N., & Nishimura, R. (2024) · JCI Insight · doi:10.1172/jci.insight.175486 · Cited by 14
Rewiring cancer: 3D genome determinants of cancer hallmarks
Amodeo, M. E., Eyler, C. E., & Johnstone, S. E. (2025) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102307 · Cited by 14
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Schütte, J., Reusch, J., Khandanpour, C., & Eisfeld, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00839 · Cited by 14
Epigenetics and immune cells in medulloblastoma
Gorini, F., Miceli, M., Antonellis, P. D., Amente, S., Zollo, M., & Ferrucci, V. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1135404 · Cited by 15
Emerging functions of DNA transposases and oncogenic mutators in childhood cancer development
Henssen, A. G., & Kentsis, A. (2018) · JCI Insight · doi:10.1172/jci.insight.123172 · Cited by 14
Merve, A., Millner, T. O., & Marino, S. (2019) · Histopathology · doi:10.1111/his.13849 · Cited by 14
Core regulatory circuitries in defining cancer cell identity across the malignant spectrum
Jahangiri, L., Tsaprouni, L., Trigg, R. M., Williams, J. A., Gkoutos, G. V., Turner, S. D., & Pereira, J. D. (2020) · Open Biology · doi:10.1098/rsob.200121 · Cited by 14
Luo, Z., Dong, X., Yu, J., Xia, Y., Berry, K., Rao, R., Xu, L., Xue, P., Chen, T., Lin, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634056 · Cited by 14
Enhancers: A Focus on Synthetic Biology and Correlated Gene Expression
Bohrer, C. H., Fursova, N. A., & Larson, D. R. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00244 · Cited by 14
Ji, Y., Li, B., Lin, R., Yuan, J. T., Han, Y., Du, Y., & Zhao, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06098-x · Cited by 14
Ekstrom, T. L., Rosok, R. M., Abdelrahman, A. M., Parassiadis, C., Manjunath, M., Dittrich, M. Y., Wang, X., Kutschat, A. P., Kanakan, A., Rajput, A., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334374 · Cited by 13
An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling
Wijaya, J., Vo, B. T., Liu, J., Xu, B., Wu, G., Wang, Y., Peng, J., Zhang, J., Janke, L. J., Orr, B. A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2054 · Cited by 14
Genetic and Epigenetic Alterations in Cancer
Teh, B. T., & Fearon, E. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00014-1 · Cited by 13
Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer
Lewis, M. W., Wiśniewska, K., King, C. M., Li, S., Coffey, A. R., Kelly, M. R., Regner, M. J., & Franco, H. L. (2022) · Cancers · doi:10.3390/cancers14071852 · Cited by 14
Wei, L., Murphy, B. L., Wu, G., Parker, M. D., Easton, J. B., Gilbertson, R. J., Zhang, J., & Roussel, M. F. (2017) · Oncotarget · doi:10.18632/oncotarget.19642 · Cited by 13
Self-citationEssentially all models are wrong, but some are useful
Simard, J. M. (2015) · Neurology · doi:10.1212/wnl.0000000000001769 · Cited by 13
The landscape of extrachromosomal circular DNA in medulloblastomaPreprint
Chapman, O. S., Luebeck, J., Wani, S., Tiwari, A., Pagadala, M., Wang, S., Larson, J. D., Lange, J. T., Wong, I. T., Dehkordi, S. R., et al. (2021) · bioRxiv · doi:10.1101/2021.10.18.464907 · Cited by 16
Self-citationHow Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care
Cipri, S., Abenavoli, L., Boccuto, L., Baldo, G. D., & Mastronuzzi, A. (2022) · Medicina · doi:10.3390/medicina58101386 · Cited by 13
Active enhancers: recent research advances and insights into disease
Zhang, J., Wang, Q., Liu, J., Duan, Y., Liu, Z., Zhang, Z., & Li, C. (2024) · Biology Direct · doi:10.1186/s13062-024-00559-x · Cited by 18
Long-range gene regulation and novel therapeutic applications
van den Heuvel, A., Stadhouders, R., Andrieu‐Soler, C., Grosveld, F. G., & Soler, É. (2015) · Blood · doi:10.1182/blood-2014-11-567925 · Cited by 12
The biogenesis and roles of extrachromosomal oncogene involved in carcinogenesis and evolution.
Wei, J., Wu, C., Meng, H., Li, M., Niu, W., Zhan, Y., Jin, L. G., Duan, Y., Zeng, Z., Xiong, W., et al. (2020) · PubMed Central · Cited by 12
Casey, M. J., Call, A. M., Thorpe, A. V., Jette, C. A., Engel, M. E., & Stewart, R. A. (2022) · iScience · doi:10.1016/j.isci.2022.105737 · Cited by 12
Mapping and Making Sense of Noncoding Mutations in the Genome
Yang, J., & Adli, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0905 · Cited by 13
Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer
Lowdon, R. F., & Wang, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174032 · Cited by 13
Deregulation of Transcriptional Enhancers in Cancer
Azad, F. M., & Atlasi, Y. (2021) · Cancers · doi:10.3390/cancers13143532 · Cited by 12
Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas
Wang, Y., Wu, H., Ren, Y., Lv, S., Ji, C., Xiang, D., Zhang, M., Lu, H., Fu, W., Liu, Q., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00890-7 · Cited by 11
Self-citation3D genome alterations and editing in pathology
Tiukacheva, E. A., Ulianov, S. V., Karpukhina, A. A., Razin, S. V., & Vassetzky, Y. S. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.005 · Cited by 14
Lee, J., Hsieh, T., Kao, Y., Tsai, C.-F., Huang, H., Shih, C., Song, H., Oda, Y., Chen, P. C.-H., Pan, C.-C., et al. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100336 · Cited by 11
Copy Number Variation in Human Health, Disease and Evolution
Sismani, C., Koufaris, C., & Voskarides, K. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3070-8_6 · Cited by 12
Tales from topographic oceans: topologically associated domains and cancer
Campbell, M. J. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0348 · Cited by 13
The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
Ghasemi, D. R., Fleischhack, G., Milde, T., & Pajtler, K. W. (2022) · Cancers · doi:10.3390/cancers14030679 · Cited by 11
Modeling three-dimensional genomic organization in evolution and pathogenesis
Diament, A., & Tuller, T. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.07.008 · Cited by 11
Oncogenic Enhancers in Leukemia
Mulet‐Lazaro, R., & Delwel, R. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0211 · Cited by 11
Kanayama, K., Imai, H., Hashizume, R., Matsuda, C., Usugi, E., HIROKAWA, Y. S., & Watanabe, M. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0741 · Cited by 11
Kim, D. T., Uloho-Okundaye, M., Frederico, S. C., Guru, S., Kim, M. J., & Chang, S. D. (2025) · Brain Sciences · doi:10.3390/brainsci15080896 · Cited by 10
Pinoli, P., Stamoulakatou, E., Nguyen, A.-P., Martínez, M. R., & Ceri, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227180 · Cited by 11
Reciprocal regulation of alternative lineages by Rgs18 and its transcriptional repressor Gfi1b
Sengupta, A., Upadhyay, G., Sen, S., & Saleque, S. (2015) · Journal of Cell Science · doi:10.1242/jcs.177519 · Cited by 10
New insights of extrachromosomal DNA in tumorigenesis and therapeutic resistance of cancer.
Qiu, H., Shao, Z., Wen, X., & Zhang, L. (2020) · PubMed Central · Cited by 10
Metadata
- Authors
- Northcott, P. A., Lee, C., Zichner, T., Stütz, A. M., Erkek, S., Kawauchi, D., Shih, D. J. H., Hovestadt, V., Zapatka, M., Sturm, D., Jones, D. T. W., Kool, M., Remke, M., Cavalli, F. M. G., Zuyderduyn, S., Bader, G. D., VandenBerg, S., Esparza, L. A., Ryzhova, M., Wang, W., Wittmann, A., Stark, S., Sieber, L., Seker-Cin, H., Linke, L., Kratochwil, F., Jäger, N., Buchhalter, I., Imbusch, C. D., Zipprich, G., Raeder, B., Schmidt, S., Diessl, N., Wolf, S., Wiemann, S., Brors, B., Lawerenz, C., Eils, J., Warnatz, H.-J., Risch, T., Yaspo, M.-L., Weber, U. D., Bartholomae, C. C., von Kalle, C., Turányi, E., Hauser, P., Sanden, E., Darabi, A., Siesjö, P., Sterba, J., Zitterbart, K., Sumerauer, D., van Sluis, P., Versteeg, R., Volckmann, R., Koster, J., Schuhmann, M. U., Ebinger, M., Grimes, H. L., Robinson, G. W., Gajjar, A., Mynarek, M., von Hoff, K., Rutkowski, S., Pietsch, T., Scheurlen, W., Felsberg, J., Reifenberger, G., Kulozik, A. E., von Deimling, A., Witt, O., Eils, R., Gilbertson, R. J., Korshunov, A., Taylor, M. D., Lichter, P., Korbel, J. O., Wechsler-Reya, R. J., & Pfister, S. M.
- Affiliations
- German Cancer Research Center (DE)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- European Molecular Biology Laboratory (DE)
- Hospital for Sick Children (CA)
- University of Toronto (CA)
- University of California San Diego (US)
- Burdenko Neurosurgery Institute (RU)
- Max Planck Institute for Molecular Genetics (DE)
- Semmelweis University (HU)
- Lund University (SE)
- Masaryk University (CZ)
- Charles University (CZ)
- Amsterdam UMC Location University of Amsterdam (NL)
- Universitätsklinikum Tübingen (DE)
- Cincinnati Children's Hospital Medical Center (US)
- St. Jude Children's Research Hospital (US)
- University Medical Center Hamburg-Eppendorf (DE)
- University of Bonn (DE)
- Cnopf´sche Kinderklinik (DE)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Heidelberg (DE)
- Heidelberg University (DE)
- European Bioinformatics Institute (GB)
- Corresponding author
- Lichter, Peter
- Korbel, Jan O.
- Pfister, Stefan M.
- ORCID
- Northcott, Paul A.
- Lee, Catherine
- Zichner, Thomas
- Stütz, Adrian M.
- Erkek, Serap
- Kawauchi, Daisuke
- Shih, David J. H.
- Hovestadt, Volker
- Zapatka, Marc
- Sturm, Dominik
- Jones, David T. W.
- Kool, Marcel
- Remke, Marc
- Cavalli, Florence M. G.
- Bader, Gary D.
- VandenBerg, Scott
- Esparza, Lourdes Adriana
- Ryzhova, Marina
- Wang, Wei
- Linke, Linda
- Jäger, Natalie
- Buchhalter, Ivo
- Imbusch, Charles D.
- Raeder, Benjamin
- Schmidt, Sabine
- Wiemann, Stefan
- Brors, Benedikt
- Warnatz, Hans-Jörg
- Yaspo, Marie-Laure
- Darabi, Anna
- Siesjö, Peter
- Sumerauer, David
- Versteeg, Rogier
- Volckmann, Richard
- Schuhmann, Martin U.
- Ebinger, Martin
- Grimes, H. Leighton
- Robinson, Giles W.
- Gajjar, Amar
- Mynarek, Martin
- Rutkowski, Stefan
- Pietsch, Torsten
- Felsberg, Jörg
- Reifenberger, Guido
- Kulozik, Andreas E.
- Witt, Olaf
- Eils, Roland
- Gilbertson, Richard J.
- Korshunov, Andrey
- Taylor, Michael D.
- Lichter, Peter
- Korbel, Jan O.
- Pfister, Stefan M.
- Venue
- Nature
- Published
- 2014-06-22
- Volume
- 511
- Issue
- 7510
- Pages
- 428-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4201514
- OpenAlex
- W2161535481
- Cited by
- 642
- References
- 47
- Citations by year
- 2026: 26 · 2025: 47 · 2024: 51 · 2023: 59 · 2022: 66 · 2021: 75 · 2020: 62 · 2019: 64 · 2018: 51 · 2017: 49 · 2016: 47 · 2015: 36 · 2014: 6
- FWCI
- 23.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Semmelweis University Repository (Semmelweis University) (submittedVersion)
- Funders
- California Institute for Regenerative Medicine (LA1-01747)
- CureSearch for Children's Cancer
- Deutsches Krebsforschungszentrum
- European Commission (260791)
- Bundesministerium für Bildung und Forschung (01KU1201A, 01GS0883)
- Deutsche Krebshilfe (109252)
- Hospital for Sick Children
- Stichting Kinderen Kankervrij
- Nationales Centrum für Tumorerkrankungen Heidelberg
- Partenariat Canadien Contre Le Cancer
- National Institutes of Health (UL1TR001425, GM 103504)
- University of California, San Diego
- Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft
- National Cancer Institute (R01CA129541, CA159859, P30CA030199, R01CA159859, P01CA096832)
- National Institute of General Medical Sciences (P41GM103504)
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- medulloblastoma, enhancer hijacking, GFI1, GFI1B, oncogene activation, super-enhancers, structural variants, Group 3 medulloblastoma, Group 4 medulloblastoma, pediatric brain tumors, oncogenic drivers
- MeSH terms
- Animals, Child, Chromosomes, Human, Pair 9, DNA-Binding Proteins, Enhancer Elements, Genetic, Humans, Medulloblastoma, Oncogenes, Proto-Oncogene Proteins, Repressor Proteins, Transcription Factors, Mice, Genomic Structural Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
